Euvolemic Hyponatremia: Definition and Clinical Characteristics
Euvolemic hyponatremia is a state of low serum sodium (typically <135 mEq/L) occurring in the absence of clinical signs of volume depletion or volume overload, most commonly caused by the syndrome of inappropriate antidiuresis (SIAD, formerly SIADH). 1
Key Diagnostic Features
Euvolemic hyponatremia is characterized by the following laboratory and clinical findings 1:
- Hyponatremia: Serum sodium <135 mEq/L (some guidelines use <130 mEq/L as the treatment threshold)
- Hypoosmolality: Plasma osmolality <275 mOsm/kg
- Inappropriately concentrated urine: Urine osmolality >100 mOsm/kg (typically >300 mOsm/kg in SIAD)
- Elevated urinary sodium: Urine sodium >20-40 mEq/L
- Clinical euvolemia: No ascites, edema, or signs of dehydration
- Normal renal, adrenal, and thyroid function
Pathophysiology
The fundamental mechanism involves impaired free water excretion due to non-osmotic release of antidiuretic hormone (ADH/vasopressin) 1, 2. This leads to:
- Increased aquaporin expression in renal collecting ducts
- Water retention disproportionate to sodium retention
- Dilutional hyponatremia despite normal or expanded total body water
- Physiologic natriuresis to maintain fluid balance at the expense of serum sodium
Clinical Context and Causes
Most Common Etiology: SIAD
SIAD accounts for the majority of euvolemic hyponatremia cases 3, 4. Common triggers include:
- Malignancies: Particularly small cell lung cancer (10-45% produce ADH, though only 1-5% become symptomatic) 1
- Pulmonary disorders: Pneumonia, tuberculosis
- CNS disorders: Meningitis, encephalitis, stroke
- Medications: SSRIs, carbamazepine, NSAIDs, thiazides
- Postoperative states: Pain, nausea, stress all stimulate non-osmotic ADH release 5
Endocrine Causes
While less common (approximately 1.6% of cases), hypothyroidism and adrenal insufficiency must be excluded before diagnosing SIAD 6, 7. These conditions are:
- Easily treatable and potentially life-threatening if missed
- Typically present with additional clinical features beyond hyponatremia
- Resolve within 1-3 days with appropriate hormone replacement 6
Clinical Significance
Symptom Spectrum
Symptoms depend on severity, acuity, and rate of development 8:
- Mild (125-135 mEq/L): Weakness, confusion, headache, nausea
- Moderate (120-125 mEq/L): More pronounced neurological symptoms
- Severe (<120 mEq/L): Seizures, coma, cardiorespiratory distress, death
Chronic Complications
Even mild chronic hyponatremia causes 8:
- Cognitive impairment and gait disturbances
- Increased fall risk (23.8% vs 16.4% in normonatremic patients)
- Higher fracture rates (23.3% vs 17.3% over 7.4 years)
- Secondary osteoporosis
Prognostic Impact
Hyponatremia is associated with 2, 8:
- Increased hospital mortality and morbidity
- Prolonged hospital stays
- Reduced survival after liver transplantation
- Poor prognosis in cirrhosis (incorporated into MELD-Na score)
Distinguishing from Other Forms
Volume status assessment is critical to differentiate euvolemic from other types 8:
- Hypovolemic hyponatremia: Dehydration, orthostasis, low urine sodium (<20 mEq/L typically), requires sodium and volume replacement
- Hypervolemic hyponatremia: Ascites, edema, heart failure, cirrhosis—characterized by expanded extracellular fluid volume 9, 2
Clinical Mimics
Cerebral salt wasting can mimic SIAD but represents true volume depletion despite similar laboratory findings 10, 3. Key distinction: extracellular fluid volume determination through clinical assessment or invasive monitoring (central venous pressure).
Common Pitfalls
Assuming all euvolemic hyponatremia is SIAD: Always screen for thiazide use and exclude thyroid/adrenal dysfunction first 3, 6
Using 0.9% saline in SIAD: Normal saline acts as a hypotonic solution in SIAD patients due to high urine osmolality, potentially worsening hyponatremia through dual effects—initial correction followed by post-infusion worsening 3
Inadequate workup: Only 69% of patients get thyroid testing and 29% get adrenal testing in real-world practice, potentially missing treatable endocrinopathies 6
Confusing acute vs chronic: Distinguishing hyponatremia present <48 hours (acute) from >48 hours (chronic) is essential for safe correction strategies 3, 11